The Impact of NOTCH Pathway Alteration on Tumor Microenvironment and Clinical Survival of Immune Checkpoint Inhibitors in NSCLC

The treatment of non-small cell lung cancer (NSCLC) with immune checkpoint inhibitors (ICIs) has been proven to induce lasting tumor remission. Screening suitable populations for immunotherapy through predictive markers is an important approach to improving the clinical benefits of patients. Evidenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaohua, Wang, Yuntao, Li, Xuebing, Feng, Gang, Hu, Sheng, Bai, Yifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302260/
https://www.ncbi.nlm.nih.gov/pubmed/34305884
http://dx.doi.org/10.3389/fimmu.2021.638763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302260/
https://www.ncbi.nlm.nih.gov/pubmed/34305884
http://dx.doi.org/10.3389/fimmu.2021.638763

Ejemplares similares